Tucker editorial direction and to toot for Economic Research and who must cohost an investigative journalist but swan lets start with the latest on the turn and this vaccine we know that 30 to 30000 people will take part in this trial but what do we know about how this trial is being conducted. There we know a couple things you did a great job of breaking down here how this all works and the reality is mcgurn is not the only one doing this pfizer is very close they say theyre conducting their own 30000 person trial thats a lot of people to be testing these vaccines i do want to Say Something about mcdermott though when you look at mcdiarmid they obviously have a relationship with the National Institutes of health that is different than other indices and the reason for that is because the in i signed the contract back in december that contract was to begin studying coronaviruses not this particular strain but coronaviruses in general and developing essentially. Artificial. Or in a seque
The clicks and moves for the c. E. O. Thing is the deflection board is comfortable saying. That is going to be better than i got up to many observers. That he and others are going to going to hear a lot about that on the morning. That you can bank on that nothing like a. Long long while the name you know is along the bottom theres a bonus which alone can shrink a lot older. Than do a new person and theyve done a move 100. 00 gandhi a new normal im going to run the phrase christ be ready to go to you then well mark you then damon join you. This is that one business show you cant afford in. Washington coming up the 1st phase 3 trial hold it 19 vaccine and underway in the United States we have an expert panel ready to what that the economy and the millions of dollars invested in the journal. In the United States the closure of the consulate is adding to the uncertainty of the cradle it. Shows today lets go and dive right in. The largest trial for a potential kogan 1000 vaccine began on mo
Prevent symptomatic covert 19 for the 1st test site to begin vaccinating is in Savannah Georgia and a total of more than 70 testing sites will be used across the country well phase one results published earlier this month showed the vaccine was generally safe and had only mild side effects this included fatigue and even muscle pain well the center for Disease Control and prevention says it typically a phase one study consists of a small number of people to see if a vaccine is safe and elicit an immune response well phase 2 is an expanded and a vaccine is given to people who have characteristics such as age and physical health and similar to those for whom the new vaccine is intended and in phase 3 the vaccine is then tested for efficacy and safety while normally it takes years to create a new vaccine scientists are working at a record pace really just hoping to have an experimental version available for Health Workers by this fall. As of a journey of vaccine which now leads the way in
Today is bad blood between beijing and the white house showing no signs of letting up and bracing for impact this is Worldwide Exchange right here on cnbc well, good morning, good afternoon, good evening, where ever you are thank you for starting here with us on cnbc. Its going to be a big week. Maybe the busiest and most important week of the summer why do we say that here you go. This will easily be the most packed earnings week of the season 167 of the s p 500 will report including 12 dow components. Well get numbers out of apple, amazon, boeing, mcdonalds, 3m, exxon and many more. Also as soon as today, Senate Republicans should unveil their latest stimulus proposal. Timing all but assures congress will miss the deadline tomorrow kicks off the feds latest policy meeting. Theyll talk about their own form of stimulus it could be again talking about new tactics to keep Interest Rates low for years to come. Also wednesday, we see rescheduled technology ceo antitrust hearing, ceo of app
The dow is down nearly 1 . The nasdaq is back in positive territory. Apple is boosting the dow adding 150 points to a decline we would be seeing. Amazon and facebook arent in that index caterpillar, chevron, exxon mobile are driving the blue chips lower. Lets start with bob who will tell us what were seeing from earning season as a whole now that were a little more than halfway through. Bob. We have a little bit of a problem. Its great may have tech earnings are fantastic but theyre not enough to move the market really forward. You can see this today just look at the sectors of whats going on. You have technology up because apple is up. You have Consumer Discretionary up because amazon is up. Everything else, the other economy is having hard time. Tech earnings are even fantastic. We have this two tier economy thats going on. Its not a split between wall street and main street its just theres a two tier economy. One part is digital and thats the megacap tech and software and the Techno